SEC Form 4 · accession 0000899243-18-004436
CytoDyn Inc. · CYDY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jordan G Naydenov
Director
Period of report
Feb 15, 2018
Accepted (ET)
Feb 16, 2018 · 6:03 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001175680
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (right to buy)F1 | $0.80 | Feb 15, 2018 | D | 50,000 | D | — | Jun 1, 2018 | Common Stock | 50,000 | 0 | D |
| Stock Options (right to buy) | $0.80 | Feb 15, 2018 | A | 50,000 | A | Feb 15, 2018 | Jun 1, 2023 | Common Stock | 50,000 | 50,000 | D |
Explanation of responses
- F1Such options were fully vested and exercisable as of the date of the reported transactions.